Martin Holst Lange

New Capabilities

Overseeing denecimig's late-stage program and regulatory filings

People with hemophilia A can bleed for hours from a small cut and bleed inside their joints for no clear reason. Novo Nordisk says its experimental injection, denecimig, kept most patients bleed-free in a long-term trial: about 71% of adults and teens and about 89% of children had zero treated bleeds.

Updated Aug 11